The impact of mental illness and psychotropic medications on sexual functioning: The evidence and management (CME)

Journal of Sexual Medicine

Volumn 6, Issue 5, 2009, Pages 1200-1211

  Clayton, Anita H ^a   Balon, Richard ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Menta illness; Psychotropic medications; Sexual dysfunction

Indexed keywords

AMFEBUTAMONE; AMINEPTINE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; BUSPIRONE; CITALOPRAM; DULOXETINE; FLUOXETINE; FLUVOXAMINE; MIRTAZAPINE; MOCLOBEMIDE; MOOD STABILIZER; NEFAZODONE; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; PLACEBO; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; ROPINIROLE; SELEGILINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SILDENAFIL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE; ZIPRASIDONE;

AMENORRHEA; ANORGASMIA; ANXIETY DISORDER; ARTICLE; CLINICAL TRIAL; DEPRESSION; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; EJACULATION DISORDER; ERECTILE DYSFUNCTION; GALACTORRHEA; GENERALIZED ANXIETY DISORDER; HUMAN; HYPERPROLACTINEMIA; INCIDENCE; LIBIDO DISORDER; MAJOR DEPRESSION; MENTAL DISEASE; MOOD DISORDER; OBSESSIVE COMPULSIVE DISORDER; ORGASM DISORDER; PANIC; POSTTRAUMATIC STRESS DISORDER; PREMATURE EJACULATION; PREVALENCE; PRIAPISM; PRIORITY JOURNAL; PSYCHOSIS; RETROGRADE EJACULATION; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SEXUAL AROUSAL DISORDER; SEXUAL DYSFUNCTION; SOCIAL PHOBIA;

EID: 65149106078     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2009.01255.x     Document Type: Article

References (79)

1. Perkins DO. Predictors of noncompliance in patients with schizophrenia. J Clin Psychiatry 2000;63:1121-8.
2. Montejo-Gonzalez AL, Licorca G, Icquierdo G. SSRI-induced sexual dysfunction: Fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther 1997;23:196-4.
3. Ashton AK, Jamerson BD, Weinstein WL, Wagoner C. Antidepressant related adverse effects impacting treatment compliance: Results of a patient survey. J Curr Ther Res 2005;66:96-106.
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th ed., text revision). Washington, DC; 2000:94.
5. Laumann E, Paik A, Rosen RC. Sexual dysfunction in the United States: Prevalence and predictors. JAMA 1999;281:537-44.
6. Casper RC, Redmond DE, Katz MM, Schaffer CB, Davis JM, Koslow SH. Somatic symptoms in primary affective disorder. Presence and relationship to the classification of depression. Arch Gen Psychiatry 1985;42:1098-104.
7. Bossini L, Fagiolini A, Valdagno M, Polizzotto NR, Castrogiovanni P. Sexual disorders in subjects treated for mood and anxiety diseases. J Clin Psychopharmacol 2007;27:310-2.
8. Safarinejad MR. Evaluation of endocrine profile and hypothalamic-pituitary-testis axis in selective serotonin reuptake-induced male sexual dysfunction. J Clin Psychopharmacol 2008;28:418-23.
9. Lankveld JJ, Grotiohann Y. Psychiatric comorbidity in heterosexual couples with sexual dysfunction assessed with the composite international diagnostic interview. Arch Sex Behav 2000;29:479-98.
10. Clayton AH. Sexual function and dysfunction in women. Psych Clinics NA 2003;26:673-82.
11. Cohen AJ. Antidepressant induced sexual dysfunction associated with low serum testosterone. 2000. Available at: http://www.mental-health-today.com/rx/testos.htm.
12. Bishop JR, Moline J, Ellingrod VL, Schultz SK, Clayton AH. Serotonin 2A-1438 G/A G protein beta 3 subunit C825T polymorphisms in patients with depression and SSRI associated sexual side effects. Neuropsychopharmacology 2006;31:2281-8.
13. Zion B, Tessler R, Cohen L, Lerer E, Raz Y, Bachner-Melman R, Gritsenko I, Nemanov L, Zohar AH, Belmaker RH, Benjamin J, Ebstein RP. Polymorphisms in the dopamine D4 receptor gene (DRD4) contribute to individual differences in human sexual behavior: Desire, arousal and sexual function. Mol Psychiatry 2006;11:782-6.
14. Palha AP, Esteves M. Drugs of abuse and sexual functioning. Adv Psychosom Med 2008;29:131-49.
15. Labbatte LA, Grimes JB, Arana GW. Serotonin reuptake antidepressant effects on sexual function in patients with anxiety disorders. Biol Psychiatry 1998;43:904-7.
16. Bodinger L, Hermesh H, Aizenberg D, Valevski A, Marom S, Shiloh R, Gothelf D, Zemishlany Z, Weizman A. Sexual function and behavior in social phobia. J Clin Psychiatry 2002;63:874-9.
17. Brien SE, Smallegange C, Gofton WT, Heaton JP, Admas MA. Development of a rat model of sexual performance anxiety: Effect of behavioral and pharmacological hyperadrenergic stimulation on APO-induced erections. Int J Impot Res 2002;14:107-15.
18. Rellini AH, Meston CM. Psychophysiological sexual arousal in women with a history of child sexual abuse. J Sex Marital Ther 2006;32:5-22.
19. Kotler M, Cohen H, Aizenberg D, Matar M, Loewenthal U, Kaplan Z, Miodownik H, Zemishlany Z. Sexual dysfunction in male posttraumatic stress disorder patients. Psychother Psychosom 2000;60:309-15.
20. Aksaray G, Yelken B, Kaptanoglu C, Oflu S, Ozaltin M. Sexuality in women with obsessive compulsive disorder. J Sex Marital Ther 2001;27:273-7.
21. Fontenelle LF, de Souza WF, de Menezes GB, Mendlowicz MV, Miotto RR, Falcao R, Versiani M, Figueira IL. Sexual function and dysfunction in Brazilian patients with obsessive-compulsive disorder and social anxiety disorder. J Nerv Ment Dis 2007;195:254-7.
22. Cyranowski JM, Frank E, Cherry C, Houck P, Kupfer DJ. Prospective assessment of sexual function in women treated for recurrent major depression. J Psychiatr Res 2004;38:267-73.
23. Williams K, Reynolds MF. Sexual dysfunction in major depression. CNS Spectr 2006; 11(9 suppl):19-23.
24. Bonierbale M, Lancon C, Tignol J. The ELIXIR study: Evaluation of sexual dysfunction in 4557 depressed patients in France. Curr Med Res Opin 2003;19:114-24.
25. Bhui K, Puffet A, Strathdee G. Sexual and relationship problems amongst patients with severe chronic psychoses. Soc Psychiatry Psychiatr Epidemiol 1997;32:459-67.
26. Aizenberg D, Zemishlany Z, Etrog PD, Weizman A. Sexual dysfunction in male schizophrenic patients. J Clin Psychiatry 1995;56:137-41.
27. MacDonald S, Halliday J, MacEWAN T, Sharkey V, Farrington S, Wall S, McCreadie RG. Nithsdale schizophrenia surveys 24: Sexual dysfunction. Case-control study. Br J Psychiatry 2003;182:50-6.
28. Terzian AC, Andreoli SB, Razzouk D, Chaves AC, Mari Jde J. Fertility and fecundity of an outpatient sample with schizophrenia. Rev Bras Psiquiatr 2006;28:305-7.
29. Tuiten A, Panhuysen G, Everaerd W, Koppeschaar H, Krabbe P, Zelissen P. The paradoxical nature of sexuality in anorexia nervosa. J Sex Marital Ther 1993;19:259-75.
30. Zanarini MC, Parachini EA, Frankenburg FR, Holman JB, Hennen J, Reich DB, Silk KR. Sexual relationship difficulties among borderline patients and axis II comparison subjects. J Nerv Ment Dis 2003;191:479-82.
31. Zemishlany Z, Weizman A. The impact of mental illness on sexual dysfunction. Adv Psychosom Med 2008;29:89-106.
32. Koseoglu N, Koseoglu H, Itil O, Oztura I, Baklan B, Ikiz AO, Eseu AA. Sexual function status in women with sleep obstructive apnea. J Sex Med 2007;4:1352-7.
33. Dannon PN, Iancu I, Lowengrub K, Gonopolsky Y, Musin E, Grunhaus L, Kotler M. A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder. Clin Neuropharmacol 2007;30:326-34.
34. Landon M, Eriksson E, Agren H, Fahlen T. Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol 1999;19:268-71.
35. Othmer E, Othmer SC. Effect of buspirone on sexual dysfunction in patients with generalized anxiety disorder. J Clin Psychiatry 1987;48:201-3.
36. Clayton AH, Pradko JF, Croft HA, Montano CB, Leadbetter RA, Bolden-Watson C, Bass KI, Donahue RM, Jamerson BD, Metz A. Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry 2002;63:357-66.
37. Clayton AH, McGarvey EL, Clavet GJ. The Changes in Sexual Functioning Questionnaire (CSFQ): Development, reliability, and validity. Psychopharmacol Bull 1997;33:731-45.
38. Clayton AH, Keller A, McGarvey EL. Burden of phase-specific sexual dysfunction with SSRIs. J Affect Disord 2006;91:27-32.
39. Dunn J, Arakawa R, Greist JH, Clayton AH. Assessing the onset of antidepressant induced sexual dysfunction using interactive voice response technology. J Clin Psychiatry 2007;68:525-32.
40. Clayton AH, Croft HA, Horrigan JP, Wightman DS, Krishen A, Richard NE, Modell JG. Bupropion extended release compared with escitalopram: Effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies. J Clin Psychiatry 2006;67:736-46.
41. Delgado P, Brannan SK, Mallinckrodt CH, Tran PV, McNamara RK, Wang F, Watkin JG, Detke MJ. Sexual functioning assessed in 4 double-blind placebo-and paroxetine-controlled trials of duloxetine for major depressive disorder. J Clin Psychiatry 2005;66:686-92.
42. McGahuey CA, Gelenberg AJ, Laukes CA, Moreno FA, Delgado PL, McKnight KM, Manber R. The Arizona Sexual Experience Scale (ASEX): Reliability and validity. J Sex Marital Ther 2000;26:25-40.
43. Detke M, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I. Duloxetine in the acute and long-term treatment of major depressive disorder: A placebo- and paroxetinecontrolled trial. Eur Neuropsychopharmacol 2004;14:57-70.
44. Clayton AH, Kornstein S, Prakash A, Mallinckrodt C, Wohlreich M. Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder. J Sex Med 2007;4:917-29.
45. Montejo AL, Llorca G, Izguierdo JA, Rico-Villademoros F, for the Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. Incidence of sexual dysfunction associated with antidepressant agents: A prospective multicenter study of 1022 outpatients. J Clin Psychiatry 2001; 62 (3 suppl): 10-21.
46. Kennedy SH, Rizvi S, Fulton K, Rasmussen J. A double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR. J Clin Psychopharmacol 2008;28:329-33.
47. Feiger A, Rickels K, Rynn MA, Zimbroff DL, Robinson DS. Selegiline transdermal system for the treatment of major depressive disorder: An 8-week, double-blind, placebo-controlled, flexible-dose titration trial. J Clin Psychiatry 2006;67:1354-61.
48. Clayton AH, Campbell BJ, Favit A, Yang Y, Moonsammy G, Piontek CM, Amsterdam JD. Symptoms of sexual dysfunction in patients treated for major depressive disorder: A meta-analysis comparing selegiline transdermal system and placebo using a patient-rated scale. J Clin Psychiatry 2007;68:1860-6.
49. Warner MD, Peabody CA, Whiteford HA, Hollister LE. Trazodone and priapism. J Clin Psychiatry 1987;48:244-5.
50. Wirshing DA, Pierre JM, Marder SR, Saunders CS, Wirshing WC. Sexual side effects of novel antipsychotic medications. Schizophr Res 2002;56:25-30.
51. Compton MT, Miller AH. Sexual side effects associated with conventional and atypical antipsychotics. J Clin Psychiatry 2001;35:89-108.
52. Smith SM, O'Keane V, Murray R. Sexual dysfunction in patients taking conventional antipsychotic medication. Br J Psychiatry 2002;181:49-55.
53. Goodnick PJ, Rodriquez L, Santana O. Antipsychotics: Impact on prolactin levels. Expert Pharmacother 2002;3:1381-91.
54. Wieck A, Haddad PM. Antipsychotic-induced hyperprolactinaemia in women: Pathophysiology, severity and consequences. Selective literature review. Br J Psychiatry 2003;182:199-2004.
55. Knegtering H, van den Bosch R, Castelein S, Bruggeman R, Sytema S, van Os J. Are sexual side effects of prolactin-raising antipsychotics reducible to serum prolactin? Psychoneuroendocrinology 2008;33:711-7.
56. Knegtering H, Boks M, Blijd C, Castelein S, van den Bosch RJ, Wiersma D. A randomized open-label comparison of the impact of olanzapine versus risperidone on sexual functioning. J Sex Marital Ther 2006;32:315-26.
57. Knegtering H, Castelein S, Bous H, van der Linde J, Bruggeman R, Kluiter H, van den Bosch RJ. A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning. J Clin Psychopharmacol 2004;24:56-61.
58. Montejo Gonzales AL, Rico-Villademoros F, Tafalla M, Majadas S, Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. A 6-month prospective observational study on the effects of quetiapine on sexual functioning. J Clin Psychopharmacol 2005;25:533-8.
59. Mir A, Shivakumar K, Williamson RJ, McAllister V, O'Keane V, Aitchinson KJ. Change in sexual dysfunction with aripiprazole: A switching or add-on study. J Psychopharmacol 2008;22:244-53.
60. Montejo AL, Rico-Villademoros F, Spanish Group for the Study of Psychotropic-Related Sexual Dysfunction. Changes in sexual function for outpatients with schizophrenia or other psychotic disorders treated with ziprasidone in clinical practice setting. A 3-month prospective, observational study. J Clin Psychopharmacol 2008;28:568-70.
61. Woodrum ST, Brown CS. Management of SSR-I-induced sexual dysfunction. Ann Pharmacother 1998;32:1209-15.
62. Clayton AH, McGarvey EL, Abouesh AI, Pinkerton RC. Substitution of an SSRI with bupropion sustained release following SSRI-induced sexual dysfunction. J Clin Psychiatry 2001;62:185-90.
63. Gelenberg AJ, McGahuey C, Laukes C, Okayli G, Moreno F, Zentner L, Delgado P. Mirtazapine substitution in SSRI-induced sexual dysfunction. J Clin Psychiatry 2000;61:356-60.
64. Feiger A, Kiev A, Shrivastava RK, Wisselink PG, Wilcox CS. Nefazodone versus sertraline in outpatients with major depression: Focus on efficacy, tolerability, and effects on sexual function and satisfaction. J Clin Psychiatry 1996;57(2 suppl):53-62.
65. Clayton AH, Zajecka J, Ferguson JM, Filipiak-Reisner JK, Brown MT, Schwartz GE. Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder. Int Clin Psychopharmacol 2003;18:151-6.
66. Schwartz TL, Nasra GS, Ashton AK, Kang D, Kumaresan H, Chilton M, Bertone F. An open-label study to evaluate switching from an SSRI or SNRI to tiagabine to alleviate antidepressant-induced sexual dysfunction in generalized anxiety disorder. Ann Clin Psychiatry 2007;19:25-30.
67. Alpert JE, Franznick DA, Hollander SB, Fava M. Gepirone extended-release treatment of anxious depression: Evidence from a retrospective subgroup analysis in patients with major depressive disorder. J Clin Psychiatry 2004;65:1069-75.
68. Clayton AH, Warnock JK, Kornstein SG, Pinkerton R, Sheldon-Keller A, McGarvey EL. A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry 2004;65:62-7.
69. Nurnberg HG, Hensley PL, Gelenberg AJ, Fava M, Lauriello J, Paine S. Treatment of antidepressant-associated sexual dysfunction with sildenafil: A randomized controlled trial. JAMA 2003;289:56-64.
70. Nurnberg HG, Hensley PL, Himan JR, Croft HA, Debattista C, Paine S. Sildenafil treatment of women with antidepressant-associated sexual dysfunction: A randomized controlled trial. JAMA 2008;300: 395-404.
71. Landen M, Eriksson E, Agren H, Fahlen T. Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol 1999;19:268-71.
72. Rosen RC, Lane RM, Menza M. Effects of SSRIs on sexual function: A critical review. J Clin Psychopharmacol 1999;19:67-85.
73. Sporn J, Ghaemi SN, Sambur MR, Rankin MA, Recht J, Sachs GS, Rosenbaum JF, Fava M. Pramipexole augmentation in the treatment of unipolar and bipolar depression: A retrospective chart review. Ann Clin Psychiatry 2000;12:137-40.
74. Perugi G, Toni C, Ruffolo G, Frare F, Akiskal H. Adjunctive dopamine agonists in treatment-resistant bipolar II depression: An open case series. Pharmacopsychiatry 2001;34:137-41.
75. Taylor MJ, Rudkin L, Hawton K. Strategies for managing antidepressant-induced sexual dysfunction: Systematic review of randomized controlled trials. J Affect Disord 2005;88:241-54.
76. Fakhoury WK, Wright D, Wallace M. Prevalence and extent of distress of adverse effects of antipsychotics among callers to a United Kingdom national mental health helpline. Int Clin Psychopharmacol 2001;16:153-62.
77. Byerly MJ, Nakonezny PA, Rush JA. Sexual functioning associated with quetiapine switch vs. risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: A randomized double-blind pilot trial. Psychiatry Res 2008;159:115-20.
78. Valevski A, Modai I, Zbarski E, Zemishlany Z, Weizman A. Effect of amantadine on sexual dysfunction in neuroleptic-treated male schizophrenic patients. Clin Neuropharmacol 1998;21:355-7.
79. Lare SP, Labbate LA. Sildenafil and erectile dysfunction. Am J Psychiatry 2000;157:2055-6.